Enveric Biosciences (ENVB) Assets Average (2011 - 2026)

Enveric Biosciences has reported Assets Average for 16 years, with the latest figure at $5.3 million in Q1 2026.

• Quarterly Assets Average rose 29.72% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 29.72% YoY) and the FY2025 annual result came in at $4.1 million, up 10.78% from the prior year.
• Assets Average grew to $5.3 million in Q1 2026 per ENVB's latest filing, from $4.7 million in the prior quarter.
• Over five years, Assets Average peaked at $30.4 million in Q2 2022 and troughed at $3.9 million in Q4 2024.
• A 5-year average of $12.0 million and a median of $6.6 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2023: Assets Average surged 97.09% in 2022, then tumbled 78.34% in 2023.
• Over 5 years, Assets Average stood at $25.2 million in 2022, then sank by 78.34% to $5.5 million in 2023, then fell by 27.9% to $3.9 million in 2024, then rose by 20.13% to $4.7 million in 2025, then gained by 12.26% to $5.3 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $5.3 million, $4.7 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.